Today, the European & Developing Countries Clinical Trials Partnership (EDCTP), RAND Europe and Baird’s CMC have published a report on the current state of health research and national funding commitments for HIV/AIDS, tuberculosis, malaria and negle...Read more » News, Announcements'
A high-level event in Cape Town, South Africa, on 2 December 2014 will celebrate the launch of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2).Read more » News, Announcements'
The results of REMoxTB, a phase III global clinical trial of new tuberculosis drug regimens, were published in the New England Journal of Medicine. The trial was led by Prof. Stephen H. Gillespie (St. Andrews University, Scotland) and conducted mainl...Read more » Announcements, News'
The diagnosis of paediatric tuberculosis is marred with difficulty, mainly due to the challenge in collecting sputum samples. A European & Developing Countries Clinical Trials-funded project (TB CHILD) has developed a new immunodiagnostic tool TAM-...Read more » News, Announcements'
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These are the results of the EDCTP-funded EARNEST trial, coordinate...Read more » News, Announcements'
The interactive EDCTP Annual Report 2013 “The First Decade” is now available on the website. It gives access to the complete Annual Report 2013 in English, French and Portuguese, the Financial Statements for 2013, and an updated online overview of al...Read more » Announcements, Press Releases'
The core function of the European & Developing Countries Clinical Trials Partnership (EDCTP) is to fund clinical trials as a means to develop new or improved interventions regarding poverty-related and neglected infectious diseases in sub-Saharan Afr...Read more »